Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Watching The Review Clock: Are US FDA Goal Date Extensions Reason For Optimism?

Jan 29 2021

• By Bridget Silverman

Stopwatch (shutterstock_157284068) — • Source: Shutterstock

Related Content

Aducanumab Approval Decision Delayed: What’s In The Major Amendment?

Jan 29 2021

Related Companies

Biogen, Inc.

Eisai Co., Ltd.

AstraZeneca PLC

FibroGen, Inc.

Additional Topics

United States Drug Review Approvals Regulation US FDA Performance Tracker Neurology BioPharmaceutical

More from Product Reviews

More from Pink Sheet

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.